BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Yumanity Therapeutics

Yumanity Therapeutics logo

Founded
2014
Geography
United States of America based
Funding
$82.100 M

Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Yumanity is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs. The initial focus of the company is neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Technologies

Pharmaceutical and Drug Discovery  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet